Govt bans on-board meals in flights as Covid-19 cases riseThe Civil Aviation Ministry said on Monday that airlines are not allowed to serve meals on flights that have a duration of less than two hours in the wake of a spike in coronavirus cases in India.The ban will come into effect from April 15, the ministry said in its latest order. However, there are no curbs on inflight meals on international flights as of now.Poonawalla-led Rising Sun's acquisition of stake in Magma Fincorp gets CCI n...

Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses

Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofis Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

COVID-19 update in India, April 12: The number of active cases rose to 12,64,698, or 9.24 per cent of the total infections. The active caseload was at its lowest at 1,35,926 on February 12, 2021, and highest at 10,17,754 on September 18, 2020

Maharashtra's cumulative case tally now stands at 34,58,996. In the past 24 hours, 258 people died from coronavirus infection in the state, taking the cumulative toll to 58,245

India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year

The e-commerce giant will also cover its delivery service partner associates, comprising Amazon Flex drivers, 'I Have Space' store partners, trucking partners, and their eligible dependents

The country will never pardon the BJP for its \"monumental failure in controlling the spread of COVID, which is taking a dangerous turn\", he told reporters

Russia's Sputnik V COVID-19 vaccine, with an effectiveness of 91.6 per cent, has been approved for restricted use in India, sources within the drug regulator's office confirmed the development on Monday. The approval to the vaccine was given based on 'very strong immunogenicity data'. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine demonstrated an efficacy rate of 91.6 per cent in the interim analysis of the phase 3 clinical trial in Russia. In February 2021, Dr Reddy's applied for the emergency use of the Russian vaccine in India. Watch the video for more.Also Read: Russia's COVID-19 vaccine Sputnik V gets govt's nod

Buyers will have to produce original prescription, RT-PCR report not older than seven days and copy of admitted patient's Aadhaar card at the time of purchasing Remdesivir at Zydus Hospitals counter

India racked up the world's highest daily tally of coronavirus infections with 168,912 new cases on Monday, overtaking Brazil as the second-most affected country by the pandemic and causing a plunge in Indian stocks and the rupee

On Day-86 of the vaccination drive on April 11, 29,33,418 vaccine doses were given. Of which, 27,01,439 beneficiaries were vaccinated across 38,398 sessions for 1st dose and 2,31,979 beneficiaries received 2nd dose of vaccine

People were seen queuing overnight outside some clothing stores and also some pubs and restaurants, which are now allowed to serve customers outdoors. Social mixing indoors remains heavily restricted and people are still expected to work from home

Around February, when cases started to decrease, people became lax towards following COVID-appropriate behaviour as they thought the virus had become ineffective, says AIIMS Director Dr Randeep Guleria

Developed by Russia's Gamaleya national center of epidemiology and microbiology, Sputnik V is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin

Renowned economist and Nobel laureate Abhijit Vinayak Banerjee has trashed the ideology that calls for lesser or limited government interventions towards uplifting the poor; Amazon India announced the launch of its 'Mentor Connect' programme on April 11, aimed at accelerating the growth of start-ups and emerging brand owners enrolled under its Amazon Launchpad initiative; Indian IT major Infosys will consider a share buyback plan in its board meeting scheduled on April 14 and is expected to hold board meetings on April 13 and 14 to approve and take on record financial results for the quarter and fiscal ended March 31, 2021. Watch this and more on News Blast.Also Read: 3rd COVID-19 vaccine in India? Expert panel to decide on Russia's Sputnik V

Shots for people aged 65 and above began at some 120 sites across the country, using Pfizer Inc's vaccine made in Europe and delivered to the regions in the past week

Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first

Deloitte CEO Punit Renjen said the Indian government has performed well in addressing the challenges posed by the COVID-19 pandemic

India bans Remdesivir exports till COVID surge abates India has banned the export of Remdesivir injection and active pharmaceutical ingredients (API) used for making the coronavirus medication till the recent surge in COVID-19 cases subsides. India has been witnessing a surge in COVID-19 cases with the second wave of the pandemic. As of Sunday, the number of active cases stood at 11.08 lakh. This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patient...